Percentage of non-cardiac adult cases in which colloids were not administered intraoperatively.
There is a lack of consistent evidence to suggest improved survival with the use of colloids as compared to crystalloids in the surgical population. Colloids are also more expensive than crystalloids. It is the expectation that providers will uphold the ASA’s Choosing Wisely program by avoiding colloids and using crystalloid instead when appropriate. Evidence to support the use of hydroxyethyl starch to prevent ovarian hyperstimulation syndrome for In Vitro Fertilization cases has been published and these cases will be excluded.
Non-cardiac cases as determined by Procedure Type: Cardiac value code = 0
Colloids are not administered during the case.
*This measure will include only valid MPOG cases as defined by the Is Valid Case phenotype.
Not applicable.
The provider signed in at the time of the colloid administration.
Colloids
Patient Position
Blood Administration Concepts:
Patient Diagnosis
Estimated Blood Loss (EBL)
Measure Author | Institution |
---|---|
Sachin Kheterpal, MD | University of Michigan |
Nirav Shah, MD | University of Michigan |
Jamie Osborne, RN | University of Michigan |
Genevive Bell | University of Michigan |
MPOG Quality Committee |
Date Reviewed | Reviewer | Institution | Review | QC Vote |
---|---|---|---|---|
10/23/2023 | Brad Taicher, MD | Duke University | Review | Modify |
Date | Criteria | Revision |
---|---|---|
11/3/2023 | Exclusion | Modified to exclude liver transplants and cases with preop albumin < 3.5g/dL |
10/6/2023 | Exclusion | Modified to exclude patient age ≤ 18 years & Organ Harvest patients (CPT: 01990) |
3/16/2022 | Exclusion | Modified to use new Cardiac phenotype |
9/1/2015 | Initial Publication |